AbbVie ABBV
NYSE ABBV
$250.93 +2.15 (+0.86%)
As of: Sep 9, 2026 · 3:59 PM EDT

AbbVie (ABBV) Debt Ratio (2012 - 2026)

AbbVie's (ABBV) quarterly Debt Ratio came in at 0.52 in Q2 2026, down 2.92% year-over-year from 0.54 in Q2 2025, and down 1.82% quarter-over-quarter from 0.53 in Q1 2026.

Analysis

AbbVie (ABBV) Debt Ratio (2012 - 2026) Analysis & Trends

AbbVie (ABBV) has reported Debt Ratio for 15 consecutive years, with 0.52 the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Debt Ratio fell 2.92% year-over-year to 0.52 in Q2 2026; TTM through Jun 2026 was 0.52, a 2.92% decrease from a year earlier, with the FY2025 full-year figure at 0.5, up 1.43% from the prior year.
  • Debt Ratio was 0.52 for Q2 2026 at AbbVie, down from 0.53 in the prior quarter.
  • Over five years, Debt Ratio peaked at 0.54 in Q2 2025 and troughed at 0.44 in Q4 2023.
  • A 5-year average of 0.49 and a median of 0.5 in 2024 frame the typical range for Debt Ratio.
  • Across the five-year window, Debt Ratio slipped 12.9% in 2022 and increased 12.69% in 2024, its largest moves.
  • Over 5 years, Debt Ratio stood at 0.46 in 2022, then declined by 3.29% to 0.44 in 2023, then gained by 12.69% to 0.5 in 2024, then advanced by 1.43% to 0.5 in 2025, then grew by 4.03% to 0.52 in 2026.
  • The last three Debt Ratio figures came in at 0.52 (Q2 2026), 0.53 (Q1 2026), and 0.5 (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Johnson & Johnson 663.08 Bn 642.33 Bn 17.26 Bn 0.30
2 AbbVie 453.04 Bn 446.51 Bn 12.70 Bn 0.52
3 Merck 370.87 Bn 363.78 Bn 12.21 Bn 0.42
4 Novartis Ag 305.29 Bn 298.00 Bn 11.24 Bn 0.08
5 Pfizer 162.10 Bn 150.70 Bn 10.94 Bn 0.31
6 Sanofi 53.95 Bn 46.98 Bn 10.79 Bn 0.17
7 Revolution Medicines 45.00 Bn 45.00 Bn - -
8 Incyte 25.47 Bn 20.94 Bn 1.57 Bn 0.00
9 United Therapeutics 20.81 Bn 18.15 Bn 683.80 Mn -
10 Jazz Pharmaceuticals 16.02 Bn 14.40 Bn 1.09 Bn 0.48
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 0.52
Mar 31, 2026 0.53
Dec 31, 2025 0.50
Sep 30, 2025 0.53
Jun 30, 2025 0.54
Mar 31, 2025 0.51
Dec 31, 2024 0.50
Sep 30, 2024 0.50
Jun 30, 2024 0.50
Mar 31, 2024 0.50
Dec 31, 2023 0.44
Sep 30, 2023 0.45
Jun 30, 2023 0.45
Mar 31, 2023 0.46
Dec 31, 2022 0.46
Sep 30, 2022 0.49
Jun 30, 2022 0.51
Mar 31, 2022 0.51
Dec 31, 2021 0.52
Sep 30, 2021 0.54